The growth of the market can be attributed to the initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, increasing prevalence of cardiovascular & respiratory diseases, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market.
According to research report the Clinical Perfusion Systems Market is projected to reach USD 1,198.8 million by 2021 from USD 989.4 million in 2016, at a CAGR of 3.9% from 2016 to 2021.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164273069
North America is estimated to account for the largest share of the global Clinical Perfusion Systems Market, followed by Europe. The Asia-Pacific region is expected to witness the highest growth in the market during the forecast period. This growth will be particularly centered on China, Japan, and India.
Perfusion systems are used to bypass cardiopulmonary systems in order to treat patients with cardiac and respiratory diseases surgically. Perfusion systems such as heart-lung machines deliver oxygen and remove carbon dioxide in patients when the heart and lungs fail to carry out the process of blood oxygenation. With the increasing prevalence of cardiovascular and respiratory diseases across the globe, the use of perfusion systems is expected to rise in the coming years.
During this research study, major players operating in the perfusion systems market in various regions have been identified, and their offerings, and their have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size.
The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region.
By component, the cardiopulmonary perfusion systems market is segmented into heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas, and other components. The oxygenators segment accounted for the largest share of the cardiopulmonary perfusion systems market in 2016.
Based on technique, the ex vivo organ perfusion systems market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held the largest share of the ex vivo organ perfusion systems market in 2016 and is also projected to grow at the highest CAGR during the forecast period.
Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=164273069
The major players in the Clinical Perfusion Systems Market include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany). The major players in the ex vivo organ perfusion system market are Lifeline Scientific, Inc. (U.S.) and XVIVO Perfusion AB (Sweden), while, Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.) are some of the leading players in the cell perfusion systems market.
Clinical Perfusion Systems Market worth $1,198.8 Million by 2021
The global Perfusion System Market size is expected to value at USD 183.8 million by 2025.
Additionally, rising preference towards Machine Perfusion (MP) by clinics, and healthcare professionals across the globe is expected to boost market growth in coming years.
Globally, the perfusion system market is predicted to grow at a CAGR of 8.7% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.However, limited supply of resources is one of the prominent factor restraining market growth, in the recent years.
Static Cold Storage (SCS) are increasingly adopted for preservation of organs, yet, they are incompetent to store high-risk organs.
Emergence of Hypothermic Machine Perfusion (HMP)is considered as an effective solution to preserve high-risk organs.Growing demand of transplantation of human body parts is credited to rising prevalence of chronic diseases, leading to the growth of perfusion system industry.
Additionally, rise in the number of organ failure is leading to the requirement of cost-effective solutions for organ preservation.
The global Perfusion System Market size is expected to value at USD 183.8 million by 2025.
Globally, the perfusion system market is predicted to grow at a CAGR of 8.7% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.However, limited supply of resources is one of the prominent factor restraining market growth, in the recent years.
Yet, recent innovation such as Machine Perfusion (MP) and Static Cold Storage (SCS) that are widely used as the preservation methods, are helping to curb this issue.
Static Cold Storage (SCS) are increasingly adopted for preservation of organs, yet, they are incompetent to store high-risk organs.
Higher success rates associated with these treatments in the recent years is estimated to boost the growth of perfusion system industry.However, decline in number of organ donors are resulting in shortage in numerous medical facilities across the globe, thus hampering market growth to certain extent.
Large number of benefits associated with early adoption of Hypothermic Machine Perfusion (HMP) such as kidney preservation alongside a cold storage, are offering required level safety and improved shelf life of an organ before transplantation procedure.During surgical procedure such as kidney transplant surgery, it aids in aggregating patient survival rate and overall success rate of the surgical procedure performed worldwide.
Global Perfusion Radiology Market: Information by Application (Cardiovascular Imaging, Ventilation Imaging, Brain Imaging, and others), End-User (Hospitals, Diagnostic Centers and others) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027Market HighlightsThe Global Perfusion Radiology Market is expected to register a CAGR of 7.48% during the forecast period, with a market value of USD 9,858 Million till 2025.
Perfusion is the passage of fluid through the lymphatic system to organs or tissues.
This is widely used for the diagnosis of chronic disorders such as cancer, brain tumor, and lung-related disorders.The growing prevalence of cardiovascular and neurological diseases, increasing geriatric population, and advancements in technology are expected to enhance market growth.
However, the stringent regulatory policies and lack of awareness for the use of advanced technologies are projected to curb the growth of the market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8419Segment AnalysisThe Global Perfusion Radiology Market, by application, has been segmented into cardiovascular imaging, ventilation imaging, brain imaging, and others.
By end-user, the global perfusion radiology market has been classified as hospitals, diagnostic centers, and others.
Regional AnalysisThe Global Perfusion Radiology Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.North America accounted for the largest market share of in 2018, owing to the incidence of cardiovascular diseases, brain tumors, and tumor-related angiogenesisEurope is anticipated to account for the second-largest market share during the forecast period.
The global Perfusion System Market size is expected to value at USD 183.8 million by 2025.
Globally, the perfusion system market is predicted to grow at a CAGR of 8.7% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.However, limited supply of resources is one of the prominent factor restraining market growth, in the recent years.
Yet, recent innovation such as Machine Perfusion (MP) and Static Cold Storage (SCS) that are widely used as the preservation methods, are helping to curb this issue.
Static Cold Storage (SCS) are increasingly adopted for preservation of organs, yet, they are incompetent to store high-risk organs.
Higher success rates associated with these treatments in the recent years is estimated to boost the growth of perfusion system industry.However, decline in number of organ donors are resulting in shortage in numerous medical facilities across the globe, thus hampering market growth to certain extent.
Large number of benefits associated with early adoption of Hypothermic Machine Perfusion (HMP) such as kidney preservation alongside a cold storage, are offering required level safety and improved shelf life of an organ before transplantation procedure.During surgical procedure such as kidney transplant surgery, it aids in aggregating patient survival rate and overall success rate of the surgical procedure performed worldwide.
The global Perfusion System Market size is expected to value at USD 183.8 million by 2025.
Additionally, rising preference towards Machine Perfusion (MP) by clinics, and healthcare professionals across the globe is expected to boost market growth in coming years.
Globally, the perfusion system market is predicted to grow at a CAGR of 8.7% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.However, limited supply of resources is one of the prominent factor restraining market growth, in the recent years.
Static Cold Storage (SCS) are increasingly adopted for preservation of organs, yet, they are incompetent to store high-risk organs.
Emergence of Hypothermic Machine Perfusion (HMP)is considered as an effective solution to preserve high-risk organs.Growing demand of transplantation of human body parts is credited to rising prevalence of chronic diseases, leading to the growth of perfusion system industry.
Additionally, rise in the number of organ failure is leading to the requirement of cost-effective solutions for organ preservation.
Global Perfusion Radiology Market: Information by Application (Cardiovascular Imaging, Ventilation Imaging, Brain Imaging, and others), End-User (Hospitals, Diagnostic Centers and others) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027Market HighlightsThe Global Perfusion Radiology Market is expected to register a CAGR of 7.48% during the forecast period, with a market value of USD 9,858 Million till 2025.
Perfusion is the passage of fluid through the lymphatic system to organs or tissues.
This is widely used for the diagnosis of chronic disorders such as cancer, brain tumor, and lung-related disorders.The growing prevalence of cardiovascular and neurological diseases, increasing geriatric population, and advancements in technology are expected to enhance market growth.
However, the stringent regulatory policies and lack of awareness for the use of advanced technologies are projected to curb the growth of the market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8419Segment AnalysisThe Global Perfusion Radiology Market, by application, has been segmented into cardiovascular imaging, ventilation imaging, brain imaging, and others.
By end-user, the global perfusion radiology market has been classified as hospitals, diagnostic centers, and others.
Regional AnalysisThe Global Perfusion Radiology Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.North America accounted for the largest market share of in 2018, owing to the incidence of cardiovascular diseases, brain tumors, and tumor-related angiogenesisEurope is anticipated to account for the second-largest market share during the forecast period.